Isis Pharma (ISIS) Misses Q3 EPS by 3c

Isis Pharma (NASDAQ: ISIS) reported Q3 EPS of ($0.23), $0.03 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $44.1 million versus the consensus estimate of $45.8 million.

For earnings history and earnings-related data on Isis Pharma (ISIS) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
• Walmart (WMT) PT Lowered to $135 at Guggenheim